1.Study on the relationship between the change of serum lipid and pathological change of coronary artery in Kawasaki disease children
Chinese Journal of Primary Medicine and Pharmacy 2012;19(6):868-869
ObjectiveTo explore the relationship between the change of serum lipid and pathological change of coronary artery in Kawasaki disease(KD) children.Methods62 children with pathological change of coronary artery in KD were divided into pathological of coronary artery group and normal coronary artery group.62 normal children were selected as control group in the same time.And then the serum lipid status of three groups were compared.ResultsThe TC (5.32 ± 1.74 ) mmol/L,( 5.24 ± 1.67 ) mmol/L,TG ( 1.67 ± 0.79 ) mmol/L,( 1.74 ± 0.65 ) mmol/L,LDL-C(2.87 ± 1.14 ) mmol/L,( 2.72 ± 1.08 ) mmol/L of KD of the two groups were lower than of the control group(3.08 ± 1.28) mmol/L,( 1.12 ±0.56) mmol/L,(2.37 ± 1.06) mmol/L(t =1.70,1.66,1.71,all P <0.05 ),and HDL-C( 1.03 ± 0.31 ) mmol/L,( 1.08 ± 0.57 ) mmol/L higher than that of the control group ( 1.65 ± 0.92 )mmol/L( t =1.54,P < 0.05 ) ; There were no differences between two coronary artery groups.After treated,TC,TG,LDL-C of normal coronary artery group were decreased ( t =1.76,1.88,1.72,all P < 0.05 ),and HDL-C was increased ( t =1.90,P < 0.05 ).ConclusionThe child ren with KD had dyslipidemia,and the dyslipidemia was recovered slowly.So,it should be an index of early diagnose for KD with coronary artery lesion.
2.Comparison of clinical effect of montelukast and ketotifen in the treatment of children with cough variant asthma
Chinese Journal of Primary Medicine and Pharmacy 2015;(23):3585-3587
Objective To compare the clinical effect of montelukast sodium and ketotifen in the treatment of children with cough variant asthma,thus to provide theoretical basis for clinical treatment.Methods 61 children with cough variant asthma were randomly divided into control group and observation group according to the digital table method,31 cases in each group.Patients of two groups were all given antispasmodic and antitussive.The control group was given ketotifen tablets drug therapy,1mg/time,2 times/d,and the observation group was treated with montelukast chewable tablets,5mg/time,1 time /d.After 8 weeks of treatment,the clinical effects were compared between the two groups.Results The total effective rate of the observation group (96.77%)was higher than that of the control group (77.42%),and the difference was statistically significant (χ2 =16.65,P <0.05).The clinical symptoms improved time of the observation group was (5.78 ±1.36)d,which was shorter than (8.45 ±2.24)d of the control group,the difference was statistically significant (t =2.71,P <0.05).The recurrence rate of the observation group (6.45%) was lower than the control group (16.13%),the difference was statistically significant (χ2 =4.67,P <0.05 ). Recurrence time of the observation group was better than that of the control group,the difference was statistically significant (t =7.98,P <0.05 ).Conclusion The curative effect of montelukast special chewing tablets in the treatment of children with bronchial asthma is obviously superior to ketotifen,has less adverse reactions.It was worthy of clinical application.
3.CLINICAL OBSERVATION AND IMMUNOLOGICAL TYPING OF MULTIPLE MYELO-MA
Benti LIU ; Yuee XU ; Peilin MENG
Medical Journal of Chinese People's Liberation Army 1982;0(03):-
The present paper reports the clinical observations on 45 cases of multiple myeloma. In 35 patients, the tumors were immunologically typed as type IgG in 16, IgA type in 9, 2 each of ?, ? type light chain disease (LCD) and double light chain disease (D-LCD). 2 of IgD type, 1 each of non-secreting type (n-SMM) and ? heavy chain disease (?HCD). Further immunological subtyping dis-closed that most of the cases belonged to IgG. ? and IgA1 ? types.
4.Diagnostic value of serum homocysteine level in patients with colon cancer
Xiuli GUO ; Shiwei YAO ; Peilin CUI ; Hui ZHAO ; Youqing XU
Clinical Medicine of China 2017;33(5):408-410
Objective To investigate the diagnostic value of serum homocysteine in the diagnosis of colon cancer.Methods The performance rate method was used to detect the level of serum homocysteine(Hcy) in colon cancer group(50 cases) who were treated in Beijing Tiantan Hospital Affiliated to Capital Medical University from March 2011 to June 2016 and control group(50 cases).The expression of independent samples t test was used to analysis of the difference of the Hcy levels between the two groups.The ROC curve was used to evaluate the value of Hcy in diagnosis of colon cancer.Results The serum Hcy level in colon cancer group was (18.6±8.9) μmol/L,in healthy control group was (10.7±4.3) μmol/L,colon cancer group serum Hcy levels were significantly higher than those of healthy control group,there was significant difference(t=5.627,P<0.01).AUC of ROC curve was 0.775,cut-off value of 18.5 μmol/L,sensitivity was 0.50,specificity was 0.94,95%CI was 0.682-0.868(P<0.01).Conclusion Serum Hcy can be used as a reference index of the diagnosis of colon cancer.
5.Clinical significance of detection of serum pepsinogen as serological biopsy in gastric cancer screening
Xiuli GUO ; Hui ZHAO ; Peilin CUI ; Shiwei YAO ; Youqing XU
Chinese Journal of Postgraduates of Medicine 2017;40(5):450-453,455
Objective To investigate the clinical significance of serum pepsinogen (PG) in gastric cancer screening. Methods The clinical data of 930 patients underwent colonoscopy were retrospectively analyzed. Among them, non chronic atrophic gastritis was in 550 cases (chronic atrophic gastritis group), chronic atrophic gastritis in 300 cases (chronic atrophic gastritis group), gastric cancer in 80 cases (gastric cancer group). The patients in chronic atrophic gastritis group were divided into mild chronic atrophic gastritis subgroup (100 cases), moderate chronic atrophic gastritis subgroup (120 cases) and severe chronic atrophic gastritis subgroup (80 cases) according to the severity of the atrophy. The levels of serum PGⅠand PGⅡwere detected by enzyme linked immunosorbent assay (ELISA) method, and the ratio of PGⅠand PGⅡ(PGR) was calculated. Results There was no statistical difference in PGⅡ among the 3 groups (F = 1.226, P>0.05). The PG Ⅰand PGR in gastric cancer group were significantly lower than those in chronic atrophic gastritis and non chronic atrophic gastritis:(70.41 ± 39.42)μg/L vs. (83.10 ± 30.08) and (165.5 ± 41.40)μg/L, 3.76 ± 2.03 vs. 5.08 ± 1.82 and 6.84 ± 1.88, those in chronic atrophic gastritis were significantly lower than those in non chronic atrophic gastritis group, there were statistical differences (P<0.05). The PG Ⅰand PGR in mild and moderate chronic atrophic gastritis subgroup were significantly higher than those in severe chronic atrophic gastritis subgroup and gastric cancer group:(95.50 ± 30.80) and (82.10 ± 31.42)μg/L vs. (70.12 ± 20.12) and (70.41 ± 39.42) μg/L, 5.84 ± 2.88 and 5.08 ± 1.89 vs. 3.90 ± 2.78 and 3.76 ± 2.03, there were statistical differences (P<0.05), but there was no statistical difference between severe chronic atrophic gastritis subgroup and gastric cancer group (P>0.05), and there was no statistical difference between mild chronic atrophic gastritis subgroup and moderate chronic atrophic gastritis subgroup (P>0.05). The receiver operating characteristic (ROC) curve was used, the optimal critical value of PG Ⅰ was 74.8μg/L, the area under curve (AUC) was 0.842, the sensitivity was 90%, specificity was 75%;the optimal critical value of PGR was 4.46, AUC was 0.837, the sensitivity was 75%, specificity was 82%;the AUC of combined detection of PG Ⅰ and PGR was 0.906, the sensitivity was 88%, specificity was 85%. Conclusions Detection of PG Ⅰ combined with PGR can be used as gastric cancer screening, the recommended level of PGⅠ≤74.80μg/L and PGR≤4.46.
6.Therapeutic effect and safety of tirofiban combined large dose statin in patients with acute myocardial infarction
Fengqiang XU ; Junjie GUO ; Peilin LIN ; Yi AN ; Xia LI
Chinese Journal of cardiovascular Rehabilitation Medicine 2014;23(4):455-458
Objective:To observe and analyze the therapeutic effect and safety of tirofiban combined large dose statin in patients with acute myocardial infarction (AMI),and evaluate its influence on myocardial perfusion and cardiac function.Methods:A total of 97 consecutive AMI patients visited to our hospital from May 2011 to January 2013, who were beyond the emergency PCI time window (≥12h),their chest pain was remissive or not further aggravated were studied.All patients were pumped with tirofiban for 48h continuously;according to combined rosuvastatin dose,they were divided into large dose group (n = 52,20mg,once/d,until one month after infarction,then changed to routine dose of 10mg,once/d)and routine dose group (n=45,10mg,once/d).All patients received se-lective PCI after 7 ~ 10d conservative treatment.Myocardial perfusion level,left ventricular ejection fraction (LVEF)on one week after PCI and 30d after AMI,enzymology changes [creatine (CK),lactate dehydrogenase (LDH)]and major adverse cardiovascular events (MACE)during hospitalization were compared between two groups.Results:Compared with routine dose group,there were significant reductions in thrombus scores in infarct related artery (IRA)[(1.32±1.01)scores vs.(0.81±0.78)scores]and corrected TIMI frame [(32.4±4.73)vs. (26.8±2.34)]in large dose group (P =0.021,P <0.001);after selective PCI,TIMI flow of large dose group was significantly better than that of routine dose group (P =0.024).On one week after PCI,LVEF:(51.4±8.9)% of large dose group was significantly higher than that of routine dose group (47.7±8.7)%,P =0.021;there were no significant difference in levels of CK and LDH between two groups on 7d and 30d after PCI (P >0.05).There was no MACE in both groups during hospitalization and 30d after PCI.Conclusion:Tirofiban combined large dose statin is safe and effective in patients with acute myocardial infarction,it can reduce intra-coronary thrombus burden,im-prove myocardial tissue perfusion and cardiac function without increasing MACE.
7.THE DISTRIBUTION OF NEURONS CONSTITUTING THE SUPERIOR MESENTERIC PLEXUS OF THE CAT—A HRP STUDY
Lixin WANG ; Weiyi MA ; Luxi XU ; Peilin ZHANG
Acta Anatomica Sinica 1953;0(01):-
The origin of nerves innervating the small intestine and oral part of the colon of the cat was studied by means of the retrograde axonal transport of HRP. Twelve adult cats were used in this experiment. The proximal cut end of the superior mesenteric plexus was immersed in HRP solution, in order to localize the neurons which contribute fibers to this plexus. Neurohistochemical procedures were processed according to Mesulam's tetramethylbenzidine (TMB) method. HRP labeled cells or fibers can be identified bilaterally in the following places: 1. The dorsal motor nucleus of the vagus nerve; about 80% of the labeled cells were found in a region from 0.4mm below to 2.0 mm above the obex, approximately at the rostral two-thirds of the middle segment of this nucleus. 2. The reticular formation of medulla; only a few cells labeled and 92% of them were located in an area from 0.2, mm to 2.7 mm above the obex. 3. The coeliac-superior mesenteric ganglion complex; almost all of the labeled cells were concentrated in the caudal part of it, near the origin of the superior mesenterie plexus. 4. The nodose ganglion; most of the oval or round labeled cells were of medium or small size, their diameters vary from 30 to 40?m, and the average total numbers of the labeled cells were 661 in the left and 695 in the right ganglion respectively. 5. The spinal ganglia; small round or oval labeled cells (25~45 ?m in diameter) were found in the left T_2 to L_5 and right T_2 to L_4 ganglia, with the most heavily labeled segments at T_(13) and L_1 (left, mean 365; right, mean 34% of all labeled cells). The average total number of the labeled Cells were 1872 in the left and 1698 in the right side. 6. Transganglionic labeled fibers were seen in the gracile nuclei of one cat, suggesting that HRP molecules are transported retrogradely in the peripheral process and anterogradely in the centrally projecting process of the same neuron of spinal ganglia.
8.Comparison of oral and gastrointestinal opportunistic pathogen contamination between tooth mugs placed up-ward and downward
Jing CHEN ; Sa CHA ; Jiehang LI ; Peilin LI ; Runqi GUO ; Jinzhi HE ; Xin XU ; Liwei ZHENG
Journal of Practical Stomatology 2015;(2):289-291
The oral and gastrointestinal opportunistic pathogen contamination was compared between tooth mugs placed upward and down-ward(n=9)for 1 4 days.Selective cultivation of the pathogens was uesd to measure the extent of contamination.The colony forming units (CFU)of colibacillus in group up and group down were 4.25 ±0.71 and 2.84 ±1 .40(P=0.046),S.mutans 89 ±0.31 and 2.84 ±1 .40 (P<0.001 ),Candida 2.28 ±1 .36 and 2.53 ±1 .92(P=0.002),fungus 2.44 ±0.99 and 0,respecitvely.Thus,tooth mug placed open-ing down is superior for health.
9.Analysis of the relation between dental arch size and upper airway morphology in patients with obstructive sleep apnea hypoventilation syndrome
Chao XU ; Yuping XIE ; Meng QIN ; Jianmin HE ; Yibo YU ; Hong KANG ; Wei MA ; Peilin HUI
Journal of Practical Stomatology 2016;32(6):834-838
Objective:To study the anatomical correlation between dental arch and the volume of upper airway in patients with obstruc-tive sleep apnea hypoventilation syndrome(OSAHS). Methods: Dental arch architecture and upper airway volume were measured by cone beam CT(CBCT) in the subjects with OSAHS(n=22) and without OSAHS(n=19). The correlation between dental arch and the supper airway volume in OSAHS patients was analyzed. Results:The length of the upper dental arch and the height of palate in OSAHS patients were larger than those of the controls(All, P<0. 05). Cross-sectional area of nasopharynx and retropalatal and the total volume of upper airway were negatively correlated with the palatal height and upper dental arch length(P<0. 05), while positively correlated with upper dental arch of molar regions(P<0. 05). Conclusion:The abnormal shape of upper dental arch is related to the airway vol-ume of nasopharynx and retropalatal region in patients with OSAHS.
10.Experimental study of 32P-CP-PLLA microparticle on human pancreatic carcinoma in nude mice
Lizhen WANG ; Min YANG ; Yuping XU ; Donghui PAN ; Peilin HUANG ; Lu LIU ; Guoqiang SHAO
Chinese Journal of Radiological Medicine and Protection 2011;31(5):527-530
Objective To study the therapeutic and toxic effects of 32 P-chromic phosphate-poly (L-lactic) acid (32p-CP-PLLA) microparticle intratumoral administration into BALB/c nude mice bearing BxPc-3 human pancreatic carcinoma.Methods Twenty four nude mice bearing tumors were injected with 0,9.3,18.5 and 37.0 M Bq 32p-CP-PLLA microparticle,respectively.The relative tumor growth rates were observed every day,and white blood cells,platelets and body weight were measured.At 14 d after administration,the tumors were removed,histological examination and immunohistochemical analysis were performed.Results The relative tumor growth rates of each treatment group was lower than 40%.Histological examination showed the degenerative necrosis at the site nearby the mircoparticle.Immunohistochemical analysis showed that the Microvessel density (MVD) and the expression of Bcl-2 in treated group were lower than those in control group.In contrast,the expression of bax in treated group were higher than those in control group.The ratio of Bcl-2/Bax protein significantly decreased in the treatment group,which were 3.83 ± 0.43,0.47 ± 0.13,1.10 ± 0.32,2.19 ± 0.57 for 0,9.3,18.5 and 37.0 MBq 32 P-CP-PLLA microparticle,respectively ( t =2.36 - 2.77,P < 0.05).MVD were 31.2 ± 2.3,23.8 ± 1.5,14.8 ±0.8,11.0 ± 1.2,respectively.Dose dependence was observed in both HE and IHC staining after 14 d treatment ( t =2.30 - 2.57,P < 0.05 ).Conclusions Intratumoral injection of 32p-CP-PLLA microparticle might be a safe,easy and effective radionuclide interventional therapy for pancreatic carcinoma.